References
Barbui T, Carobbio A, Rumi E, Finazzi G, Gisslinger H, Rodeghiero F, Randi ML, Rambaldi A, Gisslinger B, Pieri L, Bertozzi I, Casetti I, Pardanani A, Passamonti F, Vannucchi AM, Tefferi A (2014) In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology. Blood 124(19):3021–3023
Kristinsson SY, Landgren O, Samuelsson J, Björkholm M, Goldin LR (2010) Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 95(7):1216–1220
Krečak I, Holik H, Zekanović I, Morić-Perić M, Coha B, Gverić-Krečak V (2021) Autoimmune disorders and the risk of thrombotic events in polycythaemia vera. Leuk Res 110:106667
Wens I, Dalgas U, Stenager E, Eijnde BO (2013) Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review. Mult Scler 19(12):1556–1564
Guglielmelli P, Loscocco GG, Mannarelli C, Rossi E, Mannelli F, Ramundo F, Coltro G, Betti S, Maccari C, Ceglie S, Chiusolo P, Paoli C, Barbui T, Tefferi A, De Stefano V, Vannucchi AM (2021) JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis. Blood Cancer J 11(12):199
Yan Z, Gibson SA, Buckley JA, Qin H, Benveniste EN (2018) Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases. Clin Immunol 189:4–13
Thorsteinsdottir S, Bjerrum OW, Hasselbalch HC (2013) Myeloproliferative neoplasms in five multiple sclerosis patients. Leuk Res Rep 2(2):61–63
Weber MS, Prod’homme T, Youssef S, Dunn SE, Rundle CD, Lee L, Patarroyo JC, Stüve O, Sobel RA, Steinman L, Zamvil SS (2007) Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat Med 13(8):935–943
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The patient provided informed consent for this report. The General Hospital of Šibenik-Knin County, Croatia, does not require ethical approval for reporting individual cases or case series.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Krečak, I., Celić-Bunikić, S., Skelin, M. et al. Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate. Ann Hematol 101, 1885–1886 (2022). https://doi.org/10.1007/s00277-022-04839-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-022-04839-2